Addex Therapeutics (ADXN) Assets (2018 - 2025)
Addex Therapeutics' Assets history spans 8 years, with the latest figure at $8.0 million for Q4 2025.
- On a quarterly basis, Assets fell 34.68% to $8.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.0 million, a 34.68% decrease, with the full-year FY2025 number at $7.7 million, down 37.03% from a year prior.
- Assets came in at $8.0 million for Q4 2025, down from $9.2 million in the prior quarter.
- The five-year high for Assets was $29.7 million in Q1 2021, with the low at $3.8 million in Q1 2024.
- Historically, Assets has averaged $13.1 million across 5 years, with a median of $11.2 million in 2022.
- Biggest five-year swings in Assets: crashed 64.83% in 2022 and later surged 176.01% in 2025.
- Year by year, Assets stood at $24.4 million in 2021, then tumbled by 64.83% to $8.6 million in 2022, then crashed by 39.13% to $5.2 million in 2023, then skyrocketed by 132.93% to $12.2 million in 2024, then plummeted by 34.68% to $8.0 million in 2025.
- Business Quant data shows Assets for ADXN at $8.0 million in Q4 2025, $9.2 million in Q3 2025, and $10.3 million in Q2 2025.